Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

James Gierse, Atli Thorarensen, Konstantine Beltey, Erica Bradshaw-Pierce, Luz Cortes-Burgos, Troii Hall, Amy Johnston, Michael Murphy, Olga Nemirovskiy, Shinji Ogawa, Lyle Pegg, Matthew Pelc, Michael Prinsen, Mark Schnute, Jay Wendling, Steve Wene, Robin Weinberg, Arthur Wittwer, Ben Zweifel and Jaime Masferrer
Journal of Pharmacology and Experimental Therapeutics July 2010, 334 (1) 310-317; DOI: https://doi.org/10.1124/jpet.110.165845
James Gierse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atli Thorarensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantine Beltey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Bradshaw-Pierce
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luz Cortes-Burgos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Troii Hall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Johnston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Nemirovskiy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinji Ogawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyle Pegg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Pelc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Prinsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Schnute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay Wendling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Wene
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Weinberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur Wittwer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Zweifel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaime Masferrer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 387 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 387, Issue 1
1 Oct 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

James Gierse, Atli Thorarensen, Konstantine Beltey, Erica Bradshaw-Pierce, Luz Cortes-Burgos, Troii Hall, Amy Johnston, Michael Murphy, Olga Nemirovskiy, Shinji Ogawa, Lyle Pegg, Matthew Pelc, Michael Prinsen, Mark Schnute, Jay Wendling, Steve Wene, Robin Weinberg, Arthur Wittwer, Ben Zweifel and Jaime Masferrer
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 310-317; DOI: https://doi.org/10.1124/jpet.110.165845

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

James Gierse, Atli Thorarensen, Konstantine Beltey, Erica Bradshaw-Pierce, Luz Cortes-Burgos, Troii Hall, Amy Johnston, Michael Murphy, Olga Nemirovskiy, Shinji Ogawa, Lyle Pegg, Matthew Pelc, Michael Prinsen, Mark Schnute, Jay Wendling, Steve Wene, Robin Weinberg, Arthur Wittwer, Ben Zweifel and Jaime Masferrer
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 310-317; DOI: https://doi.org/10.1124/jpet.110.165845
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PAR2 inhibition reduces neuroinflammation
  • First-in-Human Phase 1 Trial with KPL-404
  • CCR6 Selective Antagonist in Homeostasis and Inflammation
Show more Inflammation, Immunopharmacology, and Asthma

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics